{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:35:37Z","timestamp":1790847337726,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T00:00:00Z","timestamp":1375401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00223-013-9770-2","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:48:39Z","timestamp":1375318119000},"page":"448-452","source":"Crossref","is-referenced-by-count":77,"title":["Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I"],"prefix":"10.1007","volume":"93","author":[{"given":"Davide","family":"Gatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Povino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Liuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fracassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,2]]},"reference":[{"key":"9770_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/JCD:6:2:173","volume":"6","author":"D Gatti","year":"2003","unstructured":"Gatti D, Colapietro F, Fracassi E, Sartori E, Antoniazzi F, Braga V, Rossini M, Adami S (2003) The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. J Clin Densitom 6:173\u2013177","journal-title":"J Clin Densitom"},{"key":"9770_CR2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino A, Cabral WA, Barnes AM, Marini JC (2011) New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 7:540\u2013557","journal-title":"Nat Rev Endocrinol"},{"key":"9770_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11154-008-9074-4","volume":"9","author":"MS Cheung","year":"2008","unstructured":"Cheung MS, Glorieux FH (2008) Osteogenesis imperfecta: update on presentation and management. Rev Endocr Metab Disord 9:153\u2013160","journal-title":"Rev Endocr Metab Disord"},{"key":"9770_CR4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","volume":"20","author":"D Gatti","year":"2005","unstructured":"Gatti D, Antoniazzi F, Prizzi R, Braga V, Rossini M, Tat\u00f2 L, Viapiana O, Adami S (2005) Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res 20:758\u2013763","journal-title":"J Bone Miner Res"},{"key":"9770_CR5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpeds.2006.03.013","volume":"149","author":"F Antoniazzi","year":"2006","unstructured":"Antoniazzi F, Zamboni G, Lauriola S, Donadi L, Adami S, Tat\u00f2 L (2006) Early bisphosphonate treatment in infants with severe osteogenesis imperfecta. J Pediatr 149:174\u2013179","journal-title":"J Pediatr"},{"key":"9770_CR6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","volume":"18","author":"S Adami","year":"2003","unstructured":"Adami S, Gatti D, Colapietro F, Fracassi E, Braga V, Rossini M, Tat\u00f2 L (2003) Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res 18:126\u2013130","journal-title":"J Bone Miner Res"},{"key":"9770_CR7","first-page":"CD005088","volume":"4","author":"CA Phillipi","year":"2008","unstructured":"Phillipi CA, Remmington T, Steiner RD (2008) Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 4:CD005088","journal-title":"Cochrane Database Syst Rev"},{"key":"9770_CR8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1359\/JBMR.051015","volume":"21","author":"G Chevrel","year":"2006","unstructured":"Chevrel G, Schott AM, Fontanges E, Charrin JE, Lina-Granade G, Duboeuf F, Garnero P, Arlot M, Raynal C, Meunier PJ (2006) Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial. J Bone Miner Res 21:300\u2013306","journal-title":"J Bone Miner Res"},{"key":"9770_CR9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bone.2004.02.023","volume":"34","author":"V Braga","year":"2004","unstructured":"Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone 34:1013\u20131016","journal-title":"Bone"},{"key":"9770_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11154-006-9007-z","volume":"7","author":"M Girotra","year":"2006","unstructured":"Girotra M, Rubin MR, Bilezikian JP (2006) The use of parathyroid hormone in the treatment of osteoporosis. Rev Endocr Metab Disord 7:113\u2013121","journal-title":"Rev Endocr Metab Disord"},{"key":"9770_CR11","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","volume":"148","author":"R Baron","year":"2007","unstructured":"Baron R, Rawadi G (2007) Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148:2635\u20132643","journal-title":"Endocrinology"},{"key":"9770_CR12","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1210\/jc.2005-2370","volume":"90","author":"SM Ott","year":"2005","unstructured":"Ott SM (2005) Sclerostin and Wnt signaling\u2014the pathway to bone strength. J Clin Endocrinol Metab 90:6741\u20136743","journal-title":"J Clin Endocrinol Metab"},{"key":"9770_CR13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","volume":"68","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot\u2013containing protein. Am J Hum Genet 68:577\u2013589","journal-title":"Am J Hum Genet"},{"key":"9770_CR14","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","volume":"283","author":"AG Robling","year":"2008","unstructured":"Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin. J Biol Chem 283:5866\u20135875","journal-title":"J Biol Chem"},{"key":"9770_CR15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bone.2006.03.017","volume":"39","author":"J Li","year":"2006","unstructured":"Li J, Sarosi I, Cattley RC, Pretorius J, Asuncion F, Grisanti M, Morony S, Adamu S, Geng Z, Qiu W, Kostenuik P, Lacey DL, Simonet WS, Bolon B, Qian X, Shalhoub V, Ominsky MS, Zhu Ke H, Li X, Richards WG (2006) Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone 39:754\u2013766","journal-title":"Bone"},{"key":"9770_CR16","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2010-2552","volume":"96","author":"D Gatti","year":"2011","unstructured":"Gatti D, Viapiana O, Idolazzi L, Fracassi E, Rossini M, Adami S (2011) The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1. J Clin Endocrinol Metab 96:1555\u20131559","journal-title":"J Clin Endocrinol Metab"},{"key":"9770_CR17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bone.2011.11.028","volume":"50","author":"D Gatti","year":"2012","unstructured":"Gatti D, Viapiana O, Adami S, Idolazzi L, Fracassi E, Rossini M (2012) Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. Bone 50:739\u2013742","journal-title":"Bone"},{"key":"9770_CR18","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/jbmr.1681","volume":"27","author":"D Gatti","year":"2012","unstructured":"Gatti D, Viapiana O, Fracassi E, Idolazzi L, Dartizio C, Povino MR, Adami S, Rossini M (2012) Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab. J Bone Miner Res 27:2259\u20132263","journal-title":"J Bone Miner Res"},{"key":"9770_CR19","volume-title":"Institute of Medicine Committee to review dietary reference intakes for vitamin D and calcium dietary reference intakes for calcium and vitamin D","year":"2010","unstructured":"Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) (2010) Institute of Medicine Committee to review dietary reference intakes for vitamin D and calcium dietary reference intakes for calcium and vitamin D. National Academics Press, Washington"},{"key":"9770_CR20","doi-asserted-by":"crossref","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of wnt\/\u03b2-catenin signaling in the treatment of osteoporosis Calcif Tissue Int (in press)","DOI":"10.1007\/s00223-013-9749-z"},{"key":"9770_CR21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"9770_CR22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2007-0711","volume":"93","author":"S Boonen","year":"2008","unstructured":"Boonen S, Marin F, Obermayer-Pietsch B, Sim\u00f5es ME, Barker C, Glass EV, Hadji P, Lyritis G, Oertel H, Nickelsen T, McCloskey EV, EUROFORS Investigators (2008) Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 93:852\u2013860","journal-title":"J Clin Endocrinol Metab"},{"key":"9770_CR23","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1210\/jc.2009-1703","volume":"95","author":"JS Finkelstein","year":"2010","unstructured":"Finkelstein JS, Wyland JJ, Lee H, Neer RM (2010) Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 95:1838\u20131845","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-013-9770-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-013-9770-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-013-9770-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:41:07Z","timestamp":1558683667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-013-9770-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,2]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["9770"],"URL":"https:\/\/doi.org\/10.1007\/s00223-013-9770-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718057912.793509196","asserted-by":"object"}]},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,2]]}}}